GlassScriptPhysician profile
Lamar Houston Moree
NPI 1306853510
$3,076.51
in general payments reported to CMS, 2019-2025
23 companies · $531 in 2025
The $531 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,594 · 2020: $79.64 · 2021: $351 · 2022: $313 · 2023: $41.21 · 2024: $167 · 2025: $531.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $739.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $738.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $1,143.88 | 2019-2021 | |
| Endologix LLC | $468.47 | 2025 | Alto Abdominal Stent Graft System |
| Penumbra, INC. | $307.91 | 2019 | |
| Scilex Pharmaceuticals INC. | $179.98 | 2019-2024 | Ztlido |
| Boston Scientific Corporation | $150.78 | 2019-2022 | |
| Pfizer INC. | $138.86 | 2019-2021 | |
| Baxter Healthcare | $94.91 | 2022-2024 | Floseal |
| Hikma Pharmaceuticals USA | $86.08 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $76.33 | 2019-2020 | |
| Vertex Pharmaceuticals Incorporated | $67.73 | 2024-2025 | |
| Almatica Pharma LLC | $59.49 | 2021-2022 | |
| Flowonix Medical Incorporated | $36.51 | 2019-2020 | |
| Nevro Corp. | $36.49 | 2024 | Senza |
| Medtronic, INC. | $34.68 | 2024-2025 | Intellis Adaptivestim |
| Avanos Medical | $30.68 | 2024 | Standard Rf Disposables |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $30.50 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $25.80 | 2019 | |
| Daiichi Sankyo INC. | $24.25 | 2019 | |
| Zyla Life Sciences, INC. | $21.96 | 2019 | |
| Nalu Medical, INC. | $18.76 | 2021 | |
| Edwards Lifesciences Corporation | $15.50 | 2019 | |
| Medtronic USA, INC. | $14.64 | 2020 | |
| Sentynl Therapeutics, INC. | $12.32 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lamar Moree listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.